Modified Immune-Modulating Particles
AssigneeCour Pharmaceuticals Development Company, Inc.
InventorsDaniel R. Getts, Rachael Terry, Nicholas King
Life of this patent
Estimating the term…
Abstract
The current invention involves the surprising finding that when carboxylated particles, such as carboxylated polystyrene, PLGA, or diamond particles are administered to subjects, inflammatory immune responses are ameliorated. Additionally, the present invention describes methods of treating inflammatory diseases by administering these same carboxylated particles.
Claims16
A pharmaceutical composition comprising carboxylated particles, wherein said particles are free from attached antigenic moieties.
(canceled)
4-6. (canceled)
10-13. (canceled)
A method of reducing the duration or severity of an inflammatory immune response in a subject comprising administering to said subject a pharmaceutical composition comprising carboxylated particles, wherein said particles are free from attached peptide or antigenic moieties.
16-25. (canceled)
27-33. (canceled)
A method of treating a viral or bacterial infection in a subject comprising administering to said subject a pharmaceutical composition comprising carboxylated particles, wherein said particles are free from attached peptide or antigenic moieties.
36-52. (canceled)
Dependencies are inferred from the claim text.